HIV & AIDS

The antibodies of 'post-treatment HIV controllers'

A very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding the fundamental mechanisms that ...

Medical research

Ivermectin does not prevent progression to severe COVID-19

Ivermectin treatment during early illness does not prevent progression to severe disease for high-risk patients with mild-to-moderate COVID-19, according to a study published online Feb. 18 in JAMA Internal Medicine.

Diseases, Conditions, Syndromes

Unvaccinated have highest SARS-CoV-2 incidence, hospitalization

(HealthDay)—Severe acute respiratory syndrome coronavirus 2 incidence and hospitalization rates are consistently higher for unvaccinated persons, and rates are lowest for those fully vaccinated with a booster, according ...

page 11 from 37